Sign in
Taking people in United StatesNo phase

How Fasting and Extra Eating Affect Energy Use in Women With Obesity

Compares how metabolism responds to short fasting and overfeeding in women before and after menopause.

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, United StatesSee the site
Trial code
Registry title
Thermogenenic Responses to Fasting and Overfeeding in Women
Status
Recruiting
People taking part
56 people, planned
Started
1 Jan 2025
Expected to end
31 Dec 2030
Type of study
Interventional, 2 groups
Treatments tested
  • Eucalaloric feeding
  • Acute Fasting
  • Acute Overfeeding
Record updated
30 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for premenopausal and postmenopausal women to compare how their bodies use energy during a 24-hour fast and during overeating.

Age
18 to 65 years. Premenopausal women: 18-45 years.
Sex
Women only.
Disease stage
Premenopausal women with regular menses (no missed cycles in the past year, cycle length 25-35 d), or postmenopausal women with no menses for at least 12 months. Women within 2 years of their final period are preferred.
Earlier treatment
Postmenopausal women cannot have used estrogen-based hormone therapy. Premenopausal women cannot have used hormonal contraceptives in the past 6 months.
Biomarker or test result
Postmenopausal women need follicular stimulating hormone (FSH) of 50 mIU/ml or more.

Main reasons for not taking part

  • Body mass index above 30 kg/m2
  • Diabetes (fasting glucose above 126 mg/dL (7 mmol/L))
  • Thyroid problems (TSH below 0.5 or above 5.0 mU/L) or uncontrolled high blood pressure, unless treated and stable
  • Surgical menopause
  • Premenopausal women who are pregnant, breastfeeding, or plan to become pregnant during the study

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age 18-45 years
  • Regular menses (no missed cycles in the previous year; cycle length 25-35 d)
  • No menses for at least 12 months
  • Follicular stimulating hormone (FSH) ≥50 mIU/ml
  • Women who are within 2 years of the final menstrual period are preferred; The primary exclusion criteria are:
  • Body mass index \> 30 kg/m2
  • Diabetes (fasting glucose \>126 mg/dL)
  • Thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) \<0.5 or \>5.0 mU/L
  • Uncontrolled hypertension defined as resting systolic BP \>150 mmHg or diastolic BP \>90 mmHg; Additional exclusion criteria for postmenopausal women
  • History or current use of estrogen-based hormonal therapy
  • Women who have undergone surgical menopause; Additional exclusion criteria for premenopausal women
  • Current hormonal contraceptive use (past 6 mo.)
  • Pregnant, lactating, or intention to become pregnant during the study period; Participants who fail the thyroid and BP criteria will be considered for enrollment if they receive treatment for these conditions and are considered stable by their treating physician

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • University of Colorado Anschutz Medical CampusAurora, United StatesContact: Edward Melanson, Ph.D.Taking people

About the trial

What the trial wants to find out

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The weight gained is primarily body fat, particularly visceral or abdominal body fat. The excess gain in abdominal fat during menopause increases the risk of chronic metabolic diseases such as heart disease and diabetes. The increase in weight and body fat with menopause may be due to changes in metabolism related to the loss of estrogen. This study plans to compare how the metabolism of premenopausal and postmenopausal women responds to changes in energy intake. The investigators will compare the changes in energy expenditure that occur during a period of acute fasting (24 hours) and a period of consuming excess calories (overfeeding).

The 2 groups in the trial

  • Premenopausal womenOther group

    Treatment: Eucalaloric feeding, Acute Fasting, and Acute Overfeeding

  • Postmenopausal womenOther group

    Treatment: Eucalaloric feeding, Acute Fasting, and Acute Overfeeding

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Thermogenic Responses to Fasting and Overfeeding in Women: a Potential Mechanism Contributing to Postmenopausal Weight Gain
Plain-language title
How Fasting and Extra Eating Affect Energy Use in Women With ObesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06610162, who can take part
Record updated
30 April 2025